Indication
Glucose-6-Phosphate Dehydrogenase Deficiency
5 clinical trials
4 products
Clinical trial
Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure With Tafenoquine or Primaquine After Quantitative G6PD Testing in ThailandStatus: Completed, Estimated PCD: 2023-08-31
Product
TafenoquineProduct
PrimaquineClinical trial
Feasibility of High Daily Dose Short Course Primaquine After G6PD Testing for the Radical Cure of Plasmodium Vivax MalariaStatus: Recruiting, Estimated PCD: 2025-05-31
Clinical trial
Feasibility of High Daily Dose Short Course Primaquine After G6PD Testing for the Radical Cure of Plasmodium Vivax MalariaStatus: Recruiting, Estimated PCD: 2025-05-31
Clinical trial
Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in BrazilStatus: Active (not recruiting), Estimated PCD: 2022-08-30
Clinical trial
Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in Glucose 6-phosphate Dehydrogenase Deficient PatientsStatus: Active (not recruiting), Estimated PCD: 2023-07-01
Product
Chloroquine